2020 IPO

SQZ Biotech Stock

SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies.

Sign up today and learn more about SQZ Biotech Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2013

Notable Investors

NanoDimension

Headquarters

Watertown MA, US

Total Funding

$101M

About SQZ Biotech Stock

SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

Investors

Funding History

April 2014$15K
October 2014$100K
June 2015$5.0M
September 2016$16.0M
December 2016$8.3M
August 2018$72.0M

Management

Director of Strategic Scientific Partnerships

Jonathan Gilbert

CEO

Armon Sharei

Chief Scientific Officer

Howard Bernstein

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo